EUVIMEDEUVIMED entdecken
Crossref

Delivery System of Nanozymes Loaded with DNAzymes and Hypoxia‐Activated Prodrug for Anti‐Tumor Metastasis

Lianxiao Zhang, Qijie Diao, Bo Li, Xuedan Yang, Teng Wang, Rui Chen, Tianze Jiang, Xia Zhao iD

Small · 2025

DOI: 10.1002/smll.202504778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Lianxiao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Ministry of Education, Shandong Provincial Key laboratory of Glycoscience and Glycotherapeutics, School of Medicine a…. Hauptthemen laut MEDLINE: Prodrugs, DNA, Catalytic, Drug Delivery Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is a common malignant tumor in women worldwide, and its high metastasis is the main reason for high mortality. Especially under hypoxic microenvironments, the upregulation of hypoxia‐inducible factor 1‐alpha (HIF‐1α) can activate the transcription factor Twist and promote tumor metastasis through epithelial‐mesenchymal transformation (EMT). Here, MnO 2 nanosheets are synthesized with oxidase‐like activity using fucoidan as a protective agent, and construct a multifunctional delivery system MnO 2 @DNAzyme‐TPZ (MDT) by loading DNAzymes and hypoxia‐activated prodrug Tirapazamine (TPZ) for tumor treatment and metastasis inhibition. MDT kills tumors by converting O 2 into reactive oxygen species (ROS) through MnO 2 nanozymes, and inhibits tumor metastasis by selectively silencing the tumor metastasis‐related Twist gene through DNAzymes. TPZ enhances tumor killing under hypoxic environments and synergistically inhibits tumor metastasis by reducing the expression of HIF‐1α. MDT significantly inhibits tumor growth and metastasis in vivo in an in situ tumor model. The strategy of combining selective gene silencing based on DNAzymes with nanozymes and hypoxia‐activated prodrug provides a new approach to anti‐tumor metastasis therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsDNA, CatalyticDrug Delivery SystemsHumansAnimalsNeoplasm MetastasisTirapazamineCell Line, TumorFemaleMiceHypoxia-Inducible Factor 1, alpha SubunitManganese CompoundsOxidesReactive Oxygen Species

Stichwörter der Autor:innen

DNAzymesbreast cancernanozymestirapazaminetumor metastasis

Substanzen

ProdrugsDNA, CatalyticTirapazamineHypoxia-Inducible Factor 1, alpha SubunitManganese Compoundsmanganese dioxideOxidesReactive Oxygen Species

Autor:innen und Institutionen

  • Key Laboratory of Marine Drugs, Ministry of Education, Shandong Provincial Key laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China.
  • Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao, 266237, China.

ORCID-Profile: Xia Zhao

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Zhang, L., Diao, Q., Li, B., Yang, X., Wang, T., Chen, R., Jiang, T., & Zhao, X. (2025). Delivery System of Nanozymes Loaded with DNAzymes and Hypoxia‐Activated Prodrug for Anti‐Tumor Metastasis. Small. https://doi.org/10.1002/smll.202504778

Vancouver

Zhang L, Diao Q, Li B, Yang X, Wang T, Chen R, et al. Delivery System of Nanozymes Loaded with DNAzymes and Hypoxia‐Activated Prodrug for Anti‐Tumor Metastasis. Small. 2025. doi:10.1002/smll.202504778

BibTeX
@article{Zhang2025,
  author = {Zhang, Lianxiao and Diao, Qijie and Li, Bo and Yang, Xuedan and Wang, Teng and Chen, Rui and Jiang, Tianze and Zhao, Xia},
  title = {Delivery System of Nanozymes Loaded with DNAzymes and Hypoxia‐Activated Prodrug for Anti‐Tumor Metastasis},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202504778}
}
Kostenlos starten →